| Cash Flow for Thermo Fisher Scientific Inc. (TMO) | | | | | | | Cash Flow | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Net Income | 761,100 | 168,935 | 198,301 | 361,837 | 172,697 | | Depreciation & Amortization | 756,800 | 240,773 | 123,272 | 66,141 | 58,548 | | Deferred Income Taxes | (90,800) | (73,627) | (5,417) | 3,004 | (16,123) | | Operating Losses | 9,000 | (733) | (12,577) | (151,168) | (16,481) | | Extraordinary Losses | - | - | - | - | - | | | Decrease in Receivables | (10,000) | 32,129 | (65,500) | (27,609) | 18,065 | | Decrease in Inventories | (14,000) | 7,860 | 6,258 | (21,465) | 28,289 | | Decrease in Other Current Assets | (13,900) | (3,237) | (2,627) | (1,009) | (819) | | Increase in Payables | 6,900 | 11,089 | 6,740 | 12,939 | (13,286) | | Increase in Other Current Liabilities | 60,800 | (147,568) | 24,338 | 7,337 | (7,499) | | Decrease in Other Working Capital | (54,200) | - | - | - | - | | Other Non-Cash Items | 55,000 | 174,485 | - | - | - | | Net Cash from Continuing Operations | 1,466,700 | 410,106 | 272,788 | 250,007 | 223,391 | | Net Cash from Discontinued Operations | 16,800 | (4,452) | (1,875) | 14,503 | (6,672) | | Cash from Operating Activities | 1,483,500 | 405,654 | 270,913 | 264,510 | 216,719 | | | | Sale of Property, Plant, Equipment | 19,200 | 5,789 | 21,812 | 5,511 | 92,248 | | Sale of Short Term Investments | 7,700 | 159,891 | 369,818 | 664,812 | 467,832 | | | Purchase of Property, Plant, Equipment | (175,500) | (76,797) | (43,545) | (49,985) | (46,136) | | Acquisitions | (486,200) | 236,505 | (933,218) | (143,010) | (134,924) | | Purchase of Short Term Investments | (8,100) | (87,821) | (231,900) | (611,095) | (179) | | Other Investment Changes, Net | 25,600 | 41,062 | (2,058) | (3,907) | (7,712) | | Cash from Investing Activities | (586,000) | 283,447 | (753,480) | 34,153 | 378,790 | | | Issuance of Debt | - | 176,774 | 935,899 | - | - | | Issuance of Capital Stock | 345,400 | 180,333 | 27,191 | 57,636 | 75,049 | | | Repayment of Debt | (472,900) | (334,585) | (570,212) | (240,756) | (271,109) | | Repurchase of Capital Stock | (898,000) | (300,000) | - | - | (88,871) | | Payment of Cash Dividends | - | - | - | - | - | | Other Financing Charges, Net | 96,800 | 17,382 | (2,018) | (548) | (376,967) | | Cash from Financing Activities | (928,700) | (260,096) | 390,860 | (183,223) | (665,606) | | | | Effect of Exchange Rate Changes | (11,100) | 24,103 | (20,853) | 15,673 | 34,942 | | Net Change in Cash | (42,300) | 453,108 | (112,560) | 131,113 | (35,155) | | | Cash at Beginning of Year | 667,400 | 214,326 | 326,886 | 195,773 | 339,067 | | Cash at End of Period | 625,100 | 667,434 | 214,326 | 326,886 | 303,912 | | | |
